Global Vitamin B12 API Market Growth 2024-2030

Global Vitamin B12 API Market Growth 2024-2030

Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.

The global Vitamin B12 API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Vitamin B12 API Industry Forecast” looks at past sales and reviews total world Vitamin B12 API sales in 2023, providing a comprehensive analysis by region and market sector of projected Vitamin B12 API sales for 2024 through 2030. With Vitamin B12 API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vitamin B12 API industry.

This Insight Report provides a comprehensive analysis of the global Vitamin B12 API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vitamin B12 API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vitamin B12 API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vitamin B12 API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vitamin B12 API.

The industry's leading manufacturers are Sanofi-Aventis, Merck and Pfizer, with a combined revenue share of 26.08% in 2019.

This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin B12 API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Cyanocobalamin Injection
Cyanocobalamin Oral
Cyanocobalamin Spray

Segmentation by Application:
Hospitals
Clinics
Drugstore
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Sanofi-Aventis
Jamieson
Novartis
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
RLG Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vitamin B12 API market?

What factors are driving Vitamin B12 API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vitamin B12 API market opportunities vary by end market size?

How does Vitamin B12 API break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.